
Work Here?
Work Here?
Work Here?
RGA is a global life and health reinsurer that helps insurance companies, pension funds, and other financial institutions manage risk by taking on specified policy risks through reinsurance agreements. It underwrites, prices, and monitors mortality, morbidity, and other life risks while earning premiums and investment income from its asset portfolio. RGA differentiates itself with data analytics and actuarial expertise to tailor risk-transfer solutions at a global scale, alongside a strong emphasis on ethical practices and data protection. Its goal is to help people live longer, more secure lives by stabilizing clients' risk and capital so they can offer reliable life and health coverage.
Industries
Data & Analytics
Quantitative Finance
Financial Services
Healthcare
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Chesterfield, Missouri
Founded
1973
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$650M
Above
Industry Average
Funded Over
1 Rounds
Reinsurance Group of America exceeded Wall Street expectations in Q2 with revenue of $6.83 billion, beating analyst estimates of $6.63 billion, and adjusted EPS of $8.89 versus estimates of $6.49. CEO Tony Cheng attributed the strong performance to robust investment returns and steady new business contributions across all regions. The quarter benefited from favourable claims experience and effective capital deployment. During the earnings call, analysts questioned management about several key topics. These included a modest decline in US traditional premium growth, sustainability of favourable mortality trends, and capital deployment targets. CFO Laura Cockrill stated the company maintains a healthy pipeline and has levers to achieve its 8%–10% EPS growth target through flexible capital allocation. Management also addressed questions about Hong Kong exposure and the Ruby Re sidecar deployment timeline.
Reinsurance Group of America reported record second-quarter results for 2026, generating $761 million in pretax adjusted operating income, or $8.89 per share after tax. The company posted an 18.4% trailing-12-month adjusted return on equity. Strong investment income, new business and favourable claims experience drove the performance. The core portfolio yield reached 4.96%, while variable investment income produced a 15% annualised return for the quarter. Economic claims came in $31 million better than expected. RGA invested $158 million in in-force transactions and returned $111 million to shareholders during the quarter. The company raised its dividend by 5.4%. Management maintained targets for 8–10% earnings per share growth, 13–15% return on equity and a 20–30% payout ratio.
Reinsurance Group of America met Wall Street's revenue expectations in Q2 2026, reporting sales of $6.64 billion, up 16.9% year on year. The global life reinsurance provider's non-GAAP profit of $8.89 per share exceeded analyst estimates by 37%. The company's net premiums earned reached $4.47 billion, representing 7.7% year-on-year growth but missing analyst expectations of $4.62 billion by 3.2%. Pre-tax profit stood at $605 million, reflecting a 9.1% margin. Over the past five years, Reinsurance Group of America has grown revenue at an 11.4% compounded annual growth rate. The company, which has operated in the reinsurance industry since 1973, helps insurance companies manage risk and meet regulatory requirements. Its market capitalisation stands at $15.49 billion.
Reinsurance Group of America reported second quarter net income of $7.01 per diluted share, compared with $2.70 per share in the prior-year quarter. Adjusted operating income reached $8.89 per diluted share, up from $4.72 per share a year earlier. The company returned $111 million to shareholders during the quarter, comprising $50 million in share repurchases and $61 million in dividends. The Board of Directors declared a regular quarterly dividend of $0.98, marking a 5.4% increase. Chief executive Tony Cheng attributed the results to favourable claims experience, strong investment returns, and the company's diversified platform. The firm's adjusted operating return on equity for the trailing twelve months stood at 17.4%.
Crum & Forster appoints Cooper to lead stop loss sales. ROI-NJ Staff(Eatontown) July 17, 2026 Crum & Forster's Accident & Health Division has appointed Matthew Cooper as vice president of stop loss sales within its Medical Business Unit. In the role, Cooper will lead the Crum & Forster Stop Loss sales team and work with stop loss and Medical Business Unit leadership to support growth across U.S. regions. His responsibilities will include new business sales, renewal performance, producer relationships and coordination among sales, underwriting, claims and other functional teams. Cooper joins Crum & Forster with 30 years of sales and sales leadership experience in the stop loss insurance market. "Matt brings outstanding stop loss insurance market knowledge, deep producer relationships, and a proven record of building high-performing sales organizations," David Webb, senior vice president of Crum & Forster Stop Loss, said. "His leadership experience, strategic mindset, and collaborative approach make him an excellent addition to our team as we continue to expand our market presence, strengthen our producer partnerships, and drive profitable growth across the business." Cooper most recently worked at Reinsurance Group of America, where he served as vice president of business development for stop loss and led the national go-to-market strategy for employer stop loss. Before that, he held leadership and sales roles at Berkley Accident and Health and Arizona Benefit Plans. Crum & Forster said his background includes sales leadership, market expansion, producer strategy and cross-functional partnerships. "I'm excited to join Crum & Forster and the Accident & Health Division at such an important time within the business," Cooper said. "C&F has built a strong reputation in the market through its underwriting expertise, service commitment, and collaborative culture. I look forward to working with the CFSL insurance team and our partners across the Medical Business Unit to help deliver positive outcomes and strong results nationwide." Cooper holds a Bachelor of Arts in political science from Fort Lewis College in Durango, Colorado, and completed Target Account Selling sales training. He has also been active in industry organizations, including the Health Care Administrators Association, Self-Insurance Institute of America, Pharmaceutical Benefit Management Institute and National Association of Health Underwriters. He also served as a contributing author to the Health Care Administrators Association's Certified Self-Funding Specialist designation. July 16, 2026 July 15, 2026 July 13, 2026 July 9, 2026 July 17, 2026
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Quantitative Finance
Financial Services
Healthcare
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Chesterfield, Missouri
Founded
1973
Find jobs on Simplify and start your career today